From Plasma to Whole Blood: Validation of Glial Fibrillary Acidic Protein (GFAP) and Neurofilament Light Chain (NfL) As Accessible Biomarkers in Stroke [0.03%]
从血浆到全血：验证神经胶质纤维酸性蛋白（GFAP）和神经丝轻链（NF-L）作为卒中生物标志物的可行性
Yuting Xue,Yinwei Gu,Jiajing Wu et al.
Yuting Xue et al.
Background: Glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) are critical blood-based biomarkers for the diagnosis and monitoring of a wide range of central nervous system (CNS) injuries. Current...
Detecting Friedewald-Substituted "Direct" LDL Cholesterol in a National Multi-Site Electronic Health Record Cohort: Prevalence and Benchmarking Impact [0.03%]
基于国家多中心电子健康记录队列检测弗里德瓦尔德替代的"直接"LDL胆固醇：流行率及基准影响分析
Ronald Doku,Nana Yaw A Osafo,John Kwagyan et al.
Ronald Doku et al.
Background: When LDL cholesterol (LDL-C) estimation equations are benchmarked against "direct" LDL-C (LDLdirect) values from electronic health records (EHRs), the implicit assumption is that reported direct values derive ...
Evaluating Patient Medians for Laboratory Quality Control Using Long-Term Carbamazepine Monitoring Data [0.03%]
长期卡马西平监测数据在实验室质量控制中评估患者均值的运用
Anders Larsson,Mats B Eriksson,Emmanuel Bäckryd et al.
Anders Larsson et al.
Background: Carbamazepine is an antiepileptic and mood-stabilizing drug with complex pharmacokinetics and a narrow therapeutic index, making therapeutic drug monitoring (TDM) essential. The therapeutic reference range for...
Severe Thrombocytopenia Complicating Iron Deficiency Anemia: A Diagnostic Challenge? [0.03%]
铁缺乏性贫血并发严重血小板减少症：诊断难题？
Lina Bahloul,Michelle Bedran,Catherine Trichet et al.
Lina Bahloul et al.
Commentary on Severe Thrombocytopenia Complicating Iron Deficiency Anemia: A Diagnostic Challenge? [0.03%]
铁缺乏性贫血伴严重血小板减少的诊治疑题——病例讨论及文献复习
Olajumoke O Oladipo
Olajumoke O Oladipo
Benchmarking Institutional Support for Point-of-Care Testing Programs: Scale, Staffing, and Operational Challenges [0.03%]
机构对床旁检测项目的支持基准：规模、人员配置和运营挑战
Min Yu,Nam K Tran,Julie L V Shaw et al.
Min Yu et al.
Background: Point-of-care testing (POCT) has expanded rapidly across healthcare systems, increasing both program scale and operational complexity. However, quantitative benchmarking data describing how POCT programs are s...
Thomas M Annesley
Thomas M Annesley
The Emerging Role of Blood-Based Biomarkers in Predicting Alzheimer's Disease [0.03%]
血液生物标志物在预测阿尔茨海默病中的作用不容小觑
Allison B Chambliss
Allison B Chambliss
Healthcare Excellence in 2026: An Unprecedented Sweep for Global Growth Economies [0.03%]
2026年医疗领域的卓越表现：全球增长型经济体的空前繁荣
Colleen Strain,Tricia Ravalico
Colleen Strain
ADLM Guidance Document on Incorporating Gender Diversity in Pathology and Laboratory Medicine [0.03%]
病理和实验室医学中性别多样性的纳入指南 документ指导病理和实验医学中包含性别均等
Tiffany A Thomas,Gabrielle N Winston-McPherson,Ina Amarillo et al.
Tiffany A Thomas et al.
Background: The first international clinical standards of care for the gender-diverse population were formulated in the late 1970s. In the last 15 years, multiple subspecialty societies within the United States have devel...
Practice Guideline
The journal of applied laboratory medicine. 2026 Jul 1;11(4):887-926. DOI:10.1093/jalm/jfag071 2026